GENERAL ONCOLOGY
General Oncology is developing a pipeline of treatments for solid metastatic cancers and cancers of the blood. They have a clinical trial underway for an investigational treatment for BRCA-related metastatic pancreatic cancer. General Oncology is sponsoring a clinical trial (Clinical Trial GO-1) for its investigational treatment for BRCA-related metastatic pancreatic cancer. The treatment involves two cycles of chemotherapy using melphalan, BCNU, vitamin B12b, and vitamin C, along with two stem cell transplants to reverse bone marrow suppression. The trial is currently open for enrollment.
GENERAL ONCOLOGY
Industry:
Health Care Medical Wellness
Founded:
2015-01-01
Address:
Burlington, Massachusetts, United States
Country:
United States
Website Url:
http://www.generaloncology.com
Total Employee:
1+
Status:
Active
Contact:
617-468-4646
Total Funding:
2.31 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Current Employees Featured
Official Site Inspections
http://www.generaloncology.com
- Host name: 192-155-95-116.ip.linodeusercontent.com
- IP address: 192.155.95.116
- Location: Atlanta United States
- Latitude: 33.7485
- Longitude: -84.3871
- Metro Code: 524
- Timezone: America/New_York
- Postal: 30301

More informations about "General Oncology"
About Us - General Oncology
2021: Our first clinical trial, the SHARON trial, opens for enrollment in New York for patients with stage IV pancreatic cancer and an inherited BRCA1 or BRCA2 mutation. The first patient in โฆSee details»
Jeff Glazier - General Oncology
He determined corporate strategy, vetted and selected clinical trial sites, managed all non-medical aspects of the SHARON Trial, selected laboratories for preclinical work, carried out all clinical trial tasks that would typically be โฆSee details»
General Oncology - Crunchbase Company Profile
General Oncology is developing a pipeline of treatments for solid metastatic cancers and cancers of the blood. They have a clinical trial underway for an โฆSee details»
General Oncology - LinkedIn
General Oncology Pharmaceutical Manufacturing Burlington, MA 366 followers General Oncology is a pharmaceutical company focused on developing drugs and methods for the cure of metastatic cancer.See details»
General Oncology, Inc. - Drug pipelines, Patents, Clinical trials
Explore General Oncology, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 1 news, and 3 literature.See details»
General Oncology, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for General Oncology, Inc. of Newton, MA. Get the latest business insights from Dun & Bradstreet.See details»
General Oncology - PitchBook
General Oncology General Information Description. Developer of a pipeline of treatments intended for solid metastatic cancers and cancers of the blood. The company focuses on โฆSee details»
General Oncology - Products, Competitors, Financials, Employees ...
Generaloncology.com. Overview & Products; Financials; Founded Year 2015. Stage Unattributed - II | Alive. Total Raised $42M. Last Raised $7.2M | 5 yrs ago. About General Oncology. โฆSee details»
Contact Us - General Oncology
617.GO8.GOGO (617.468.4646) [email protected] Mailing address: Gener al Oncology, Inc.. 202 Washington Street. Suite 318. Brookline, MA 02445See details»
General Oncology Information - RocketReach
Generaloncology.com; 5+ 508415XXXX; 617965XXXX; 617244XXXX; 617965XXXX; 617969XXXX; 978887XXXX; View Similar People. Related Companies No related companies โฆSee details»
Dr. Geoffrey Watson | Sinai Health
Dr. Geoffrey Watson is a Staff Medical Oncologist at Mount Sinai Hospital and an Assistant Professor of Medicine at the University of Toronto.See details»
Choose the Right Organizational Model for Oncology Practice
Jul 1, 2018 Baird says this part of the organization is essential to practice success. โThe best way to optimize the model is to make sure you have the best possible information technology,โ โฆSee details»
OneOncology Launches to Enable Better Cancer Care in โฆ
Sep 12, 2018 Three leading oncology practices unite with partners in technology and finance to announce the launch of OneOncology, a patient-centric, physician-driven, and technology โฆSee details»
About Us - General Oncology
Nov 7, 2022 For media inquiries, please contact Jeff Glazier via [email protected]. Recent Press Releases. Press Releases. November 15, 2022 Boston Patent Law Association โฆSee details»
Focus on Oncology - Jewish General Hospital Foundation
Renowned oncologist and Director, Dr. Gerald Batist, shares his unique perspective on the JGHโs Segal Cancer Centre, and how this state-of-the-art facility and incomparable interdisciplinary โฆSee details»
An Organizational Guideline for Gynecologic Oncology Services
Objectives Documented variations in practice compelled the need to establish a network that would facilitate the flow of patients through the care continuum of a provincial health care โฆSee details»
Press Release: BPLA Honor | General Oncology
Nov 15, 2022 In addition to the investigational treatment in the SHARON Trial, the company has a pipeline of drug candidates for other solid tumors, as well as for myeloma, lymphoma, and โฆSee details»
General Oncology, Inc. - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅๆถ
ไบ่งฃGeneral Oncology, Inc.ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็1้กนไธดๅบ่ฏใSee details»
About Us | General Oncology
Phase 1 We are developing the combination of melphalan, BCNU, vitamin B12b, and vitamin C for the treatment of Stage IV cancers in patients with an inherited BRCA1, BRCA2, or PALB2 โฆSee details»